LECTURE 4 TOOLS OF STRATEGY ANALYSIS ANALYSIS OF THE INTERNAL ENVIRONMENT 1 Analysing resources and capabilities: the interface between strategy and the firm 2 Mario Calderini‚ Alessandra Colombelli TECHNOLOGY STRATEGY AND MARKETING 2 Resource-based view of the firm Firm is a pool of resources and capabilities that are the primary determinants of its strategy Capabilities are the “roots of competitiveness‚” source of new products‚ and foundation for strategy The greater
Premium Strategic management
AG (referred to as Syngenta throughout this report) is a company originating from Switzerland‚ registered as a stock corporation that has issued registered shares to investors‚ and was formed in the year 2000‚ when the two companies Novartis and AstraZeneca merged. The main foci of Syngenta are the production and selling of seeds and chemicals to the agricultural sector. Moreover‚ the company is active in the biotechnological field and genomic research. The markets of this company are very large and
Premium Strategic management Agriculture Mass media
HOW DIFFERENT ARE BRANDING STRATEGIES IN THE PHARMACEUTICAL INDUSTRY VERSUS FAST MOVING CONSUMER GOODS? Abstract The objective of this paper is to analyse the branding strategies used currently in the pharmaceutical industry and compare it to the best practices in Fast Moving Consumer goods. First the authors review the differences in the way branding is defined and organised in pharmaceuticals versus FMCG and identify why branding could be leveraged in the pharmaceutical industry to help
Premium Brand Brand management Branding
Berkshire Hathaway From Wikipedia‚ the free encyclopedia Jump to: navigation‚ search Berkshire Hathaway Inc. Type Public (NYSE: BRKA‚ NYSE: BRKB) Founded 1839 (as Valley Falls Company) Founder Warren Buffett Headquarters Omaha‚ Nebraska Area served USA Key people Warren E. Buffett (Chairman) & (CEO) Charles T. Munger (Vice Chairman) Industry Property and casualty insurance‚ Diversified investments Products Conglomerate focused on insurance Market cap US$ 196
Premium Berkshire Hathaway
Getting the Marketing Mix Right Marketers have a wide array of selling tools at their disposal‚ but lack an effective method for predicting their success. Associate Professor Thomas J. Steenburgh and collaborators offer a new model for guiding their marketing investments. Key concepts include: Discrete choice models commonly used to evaluate marketing strategies often provide misleading results‚ leaving managers with the inability to accurately measure how they can get the best bang for their
Premium Marketing
Global Pharmaceutical Industry Analysis September 21 2009 Dibakar Mitra (P08017) I Manoj Joshi (B08026) Table of Contents EXECUTIVE SUMMARY 3 INTRODUCTION 4 ORIGIN AND EVOLUTION 5 ENVIRONMENT ANALYSIS (PEST) 7 STRUCTURAL INDUSTRY ANALYSIS (PORTER) 8 STRATEGIC ISSUES FACING THE INDUSTRY 11 STRATEGIC GROUPS IN THE INDUSTRY ACCORDING TO MARKET/DRUG/FUNCTIONING 15 PROCESS FLOW: IMPORTANT FUNCTIONS 16 STRATEGIC RESPONSES TO CHALLENGES: SIMPLE CORRELATION BETWEEN GROUP
Premium Pharmaceutical industry
www.pwc.com/pharma2020 Pharma 2020: Supplying the future Which path will you take? Pharmaceuticals and Life Sciences Previous publications in this series include: Published in June 2007‚ this paper highlights a number of issues that will have a major bearing on the industry by 2020. The publication outlines the changes we believe will best help pharmaceutical companies realise the potential the future holds to enhance the value they provide to shareholders and society alike
Premium Supply chain management Supply chain
GLAXOSMITHKLINE PHARMACEUTICALS GlaxoSmithKline plc is a global healthcare group engaged in the creation‚ discovery‚ development‚ manufacture and marketing of pharmaceutical and consumer health related products. The company operated in two segments: Pharmaceuticals (Prescription pharmaceuticals and vaccines)‚ and Consumer Healthcare. STRATEGIC BUSINESS UNIT – PHARMACEUTICALS MANUFACTURING AND MARKETING STRATEGIC GROUP FOR THE SBU – CONTRACT MANUFACTURING Company Information &
Premium Pharmaceutical industry
Exhibit 3.1 Strategic capabilities and competitive advantage Exhibit 3.2 Strategic capability: the terminology Exhibit 3.3 Sources of cost efficiency Exhibit 3.4 The experience curve Exhibit 3.5 Criteria for inimitability of strategic capabilities Analyzing Resources & Capabilities OUTLINE • The role of resources and capabilities in strategy formulation. • The resources of the firm • Organizational capabilities • Appraising the profit potential of resources and
Premium Knowledge Knowledge management Tacit knowledge
Is it possible to build better bureaucracies? Introduction The conception of bureaucracy is one of the most dominant notions in both organization theory and social science. It plays a significant role in modern society. (Clawson‚ 1980) Ever since the basic characteristics of bureaucracy were formulated by Max Weber‚ it has been suffered from derogatory remarks and harsh criticism and from various perspectives. For example‚ feminists such as Kathy Fergusson (1984)‚ liberals such as Mills (1951)
Premium Bureaucracy